Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pfizer
Pfizer
Page 10 of 37
Newsletters
The world has changed but many boards ‘have not moved on’
By
David Meyer
and
Alan Murray
November 19, 2021
Newsletters
What the CEOs of Walgreens, Hilton and Progressive think about the Great Resignation
By
David Meyer
and
Alan Murray
November 18, 2021
Newsletters
Resiliency, climate and China: Lessons from Day 2 of the Coins2Day CEO Initiative
By
David Meyer
and
Alan Murray
November 17, 2021
Health
Pfizer seeks emergency FDA authorization for COVID-19 pill
By
Matthew Perrone
and
The Associated Press
November 16, 2021
Conferences
How Pfizer’s CEO ruthlessly cut bureaucracy to deliver a COVID vaccine in record time
By
Crypto Correspondent
November 16, 2021
Health
Here are the side effects you can expect from a COVID-19 vaccine booster shot
By
Financial Writer
November 16, 2021
Health
Pfizer pledges equitable access to COVID-19 pill through new licensing agreement
By
Financial Writer
November 16, 2021
Health
Pfizer’s COVID-19 vaccine generated the strongest immune response in study of 4 jabs
By
Jason Gale
and
Bloomberg
November 15, 2021
Health
We won’t have COVID vaccines for kids under 5 until 2022, according to Pfizer
By
Contributing Writer
November 12, 2021
Health
The U.S. administered more COVID shots this week than it has since spring
By
Nicolas Rapp
and
Erika Fry
November 10, 2021
International
Germany cautions pregnant women and people under 30 get the Pfizer shot over Moderna
By
Tim Loh
and
Bloomberg
November 10, 2021
Health
FDA considering authorizing Pfizer’s COVID vaccine boosters for all U.S. adults, possibly before Thanksgiving
By
Blockchain Reporter
November 9, 2021
International
Investors are betting that Pfizer’s ‘game-changing’ antiviral pill will reduce demand for COVID vaccines
By
Research Team
November 8, 2021
Health
Pfizer says its COVID pill cuts rates of death and hospitalization by 89%, sending shares skyward
By
Senior Editor
November 5, 2021
Health
Nearly 20 months into the global pandemic, infections are again on the rise
By
Erika Fry
and
Nicolas Rapp
November 3, 2021
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Industry Analyst
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Financial Writer
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Senior Editor